25 XP   0   0   10

Hofseth Biocare ASA
Buy, Hold or Sell?

Let's analyse Hofseth Biocare ASA together

PenkeI guess you are interested in Hofseth Biocare ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hofseth Biocare ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hofseth Biocare ASA

I send you an email if I find something interesting about Hofseth Biocare ASA.

Quick analysis of Hofseth Biocare ASA (30 sec.)










What can you expect buying and holding a share of Hofseth Biocare ASA? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.38
Expected worth in 1 year
kr0.46
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
kr0.08
Return On Investment
4.0%

For what price can you sell your share?

Current Price per Share
kr2.10
Expected price per share
kr1.9 - kr2.76
How sure are you?
50%

1. Valuation of Hofseth Biocare ASA (5 min.)




Live pricePrice per Share (EOD)

kr2.10

Intrinsic Value Per Share

kr-2.17 - kr-1.74

Total Value Per Share

kr-1.80 - kr-1.37

2. Growth of Hofseth Biocare ASA (5 min.)




Is Hofseth Biocare ASA growing?

Current yearPrevious yearGrowGrow %
How rich?$13.4m$12.7m$755.4k5.6%

How much money is Hofseth Biocare ASA making?

Current yearPrevious yearGrowGrow %
Making money-$12.4m-$11.4m-$989.8k-8.0%
Net Profit Margin-114.1%-144.3%--

How much money comes from the company's main activities?

3. Financial Health of Hofseth Biocare ASA (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#644 / 1019

Most Revenue
#299 / 1019

Most Profit
#594 / 1019

Most Efficient
#585 / 1019

What can you expect buying and holding a share of Hofseth Biocare ASA? (5 min.)

Welcome investor! Hofseth Biocare ASA's management wants to use your money to grow the business. In return you get a share of Hofseth Biocare ASA.

What can you expect buying and holding a share of Hofseth Biocare ASA?

First you should know what it really means to hold a share of Hofseth Biocare ASA. And how you can make/lose money.

Speculation

The Price per Share of Hofseth Biocare ASA is kr2.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hofseth Biocare ASA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hofseth Biocare ASA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.38. Based on the TTM, the Book Value Change Per Share is kr0.02 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hofseth Biocare ASA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.03-1.5%-0.03-1.5%-0.03-1.4%-0.02-1.2%-0.02-1.0%
Usd Book Value Change Per Share0.000.1%0.000.1%-0.03-1.3%0.010.2%0.000.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.1%0.000.1%-0.03-1.3%0.010.2%0.000.2%
Usd Price Per Share0.30-0.30-0.63-0.57-0.41-
Price to Earnings Ratio-9.48--9.48--21.56--24.00--23.01-
Price-to-Total Gains Ratio155.92-155.92--22.09-58.37-34.09-
Price to Book Ratio8.74-8.74-19.42-16.81-19.26-
Price-to-Total Gains Ratio155.92-155.92--22.09-58.37-34.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.19026
Number of shares5255
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.01
Gains per Quarter (5255 shares)10.0526.91
Gains per Year (5255 shares)40.18107.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104030010898
2080700215206
301211100323314
401611500430422
502011900538530
602412300646638
702812700753746
803213100861854
903623500969962
100402390010761070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%7.03.00.070.0%7.03.00.070.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%7.03.00.070.0%7.03.00.070.0%

Fundamentals of Hofseth Biocare ASA

About Hofseth Biocare ASA

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol, joint, eye, brain, and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome, and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2009 and is headquartered in Ålesund, Norway.

Fundamental data was last updated by Penke on 2024-03-31 15:03:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hofseth Biocare ASA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hofseth Biocare ASA earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • A Net Profit Margin of -114.1% means that kr-1.14 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hofseth Biocare ASA:

  • The MRQ is -114.1%. The company is making a huge loss. -2
  • The TTM is -114.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-114.1%TTM-114.1%0.0%
TTM-114.1%YOY-144.3%+30.3%
TTM-114.1%5Y-135.4%+21.3%
5Y-135.4%10Y-215.4%+80.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-114.1%-197.2%+83.1%
TTM-114.1%-210.4%+96.3%
YOY-144.3%-279.3%+135.0%
5Y-135.4%-436.8%+301.4%
10Y-215.4%-599.3%+383.9%
1.1.2. Return on Assets

Shows how efficient Hofseth Biocare ASA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • -33.4% Return on Assets means that Hofseth Biocare ASA generated kr-0.33 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hofseth Biocare ASA:

  • The MRQ is -33.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -33.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.4%TTM-33.4%0.0%
TTM-33.4%YOY-30.4%-3.0%
TTM-33.4%5Y-32.3%-1.1%
5Y-32.3%10Y-37.1%+4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.4%-13.6%-19.8%
TTM-33.4%-12.9%-20.5%
YOY-30.4%-11.9%-18.5%
5Y-32.3%-14.2%-18.1%
10Y-37.1%-16.2%-20.9%
1.1.3. Return on Equity

Shows how efficient Hofseth Biocare ASA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • -92.4% Return on Equity means Hofseth Biocare ASA generated kr-0.92 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hofseth Biocare ASA:

  • The MRQ is -92.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -92.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-92.4%TTM-92.4%0.0%
TTM-92.4%YOY-89.7%-2.7%
TTM-92.4%5Y-78.7%-13.6%
5Y-78.7%10Y-117.8%+39.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-92.4%-17.0%-75.4%
TTM-92.4%-16.1%-76.3%
YOY-89.7%-15.4%-74.3%
5Y-78.7%-20.0%-58.7%
10Y-117.8%-21.1%-96.7%

1.2. Operating Efficiency of Hofseth Biocare ASA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hofseth Biocare ASA is operating .

  • Measures how much profit Hofseth Biocare ASA makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • An Operating Margin of -106.8% means the company generated kr-1.07  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hofseth Biocare ASA:

  • The MRQ is -106.8%. The company is operating very inefficient. -2
  • The TTM is -106.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-106.8%TTM-106.8%0.0%
TTM-106.8%YOY-135.3%+28.5%
TTM-106.8%5Y-124.1%+17.3%
5Y-124.1%10Y-195.5%+71.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-106.8%-286.1%+179.3%
TTM-106.8%-224.4%+117.6%
YOY-135.3%-288.4%+153.1%
5Y-124.1%-475.2%+351.1%
10Y-195.5%-624.7%+429.2%
1.2.2. Operating Ratio

Measures how efficient Hofseth Biocare ASA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.83 means that the operating costs are kr2.83 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 2.831. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.831. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.831TTM2.8310.000
TTM2.831YOY3.090-0.258
TTM2.8315Y2.995-0.164
5Y2.99510Y4.128-1.133
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8312.997-0.166
TTM2.8313.247-0.416
YOY3.0903.766-0.676
5Y2.9955.675-2.680
10Y4.1287.857-3.729

1.3. Liquidity of Hofseth Biocare ASA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hofseth Biocare ASA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.02 means the company has kr1.02 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 1.021. The company is just able to pay all its short-term debts.
  • The TTM is 1.021. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.021TTM1.0210.000
TTM1.021YOY1.128-0.108
TTM1.0215Y1.606-0.585
5Y1.60610Y1.274+0.332
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0213.930-2.909
TTM1.0214.251-3.230
YOY1.1285.436-4.308
5Y1.6066.045-4.439
10Y1.2746.363-5.089
1.3.2. Quick Ratio

Measures if Hofseth Biocare ASA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • A Quick Ratio of 0.26 means the company can pay off kr0.26 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.2550.000
TTM0.255YOY0.380-0.124
TTM0.2555Y0.936-0.681
5Y0.93610Y0.694+0.242
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2553.629-3.374
TTM0.2554.065-3.810
YOY0.3805.397-5.017
5Y0.9365.993-5.057
10Y0.6946.277-5.583

1.4. Solvency of Hofseth Biocare ASA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hofseth Biocare ASA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hofseth Biocare ASA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.64 means that Hofseth Biocare ASA assets are financed with 63.8% credit (debt) and the remaining percentage (100% - 63.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 0.638. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.638. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.638TTM0.6380.000
TTM0.638YOY0.663-0.024
TTM0.6385Y0.573+0.065
5Y0.57310Y0.650-0.076
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6380.332+0.306
TTM0.6380.334+0.304
YOY0.6630.268+0.395
5Y0.5730.366+0.207
10Y0.6500.390+0.260
1.4.2. Debt to Equity Ratio

Measures if Hofseth Biocare ASA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 176.4% means that company has kr1.76 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 1.764. The company is just able to pay all its debts with equity.
  • The TTM is 1.764. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.764TTM1.7640.000
TTM1.764YOY1.954-0.190
TTM1.7645Y1.422+0.342
5Y1.42210Y2.183-0.761
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7640.381+1.383
TTM1.7640.390+1.374
YOY1.9540.334+1.620
5Y1.4220.434+0.988
10Y2.1830.466+1.717

2. Market Valuation of Hofseth Biocare ASA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Hofseth Biocare ASA generates.

  • Above 15 is considered overpriced but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • A PE ratio of -9.48 means the investor is paying kr-9.48 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hofseth Biocare ASA:

  • The EOD is -6.050. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.479. Based on the earnings, the company is expensive. -2
  • The TTM is -9.479. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.050MRQ-9.479+3.428
MRQ-9.479TTM-9.4790.000
TTM-9.479YOY-21.556+12.077
TTM-9.4795Y-24.001+14.522
5Y-24.00110Y-23.006-0.995
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.050-2.315-3.735
MRQ-9.479-2.560-6.919
TTM-9.479-2.664-6.815
YOY-21.556-4.122-17.434
5Y-24.001-6.258-17.743
10Y-23.006-6.108-16.898
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hofseth Biocare ASA:

  • The EOD is -13.181. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -20.650. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -20.650. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.181MRQ-20.650+7.469
MRQ-20.650TTM-20.6500.000
TTM-20.650YOY-27.389+6.739
TTM-20.6505Y-33.088+12.439
5Y-33.08810Y-69.409+36.321
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.181-3.067-10.114
MRQ-20.650-3.251-17.399
TTM-20.650-3.545-17.105
YOY-27.389-5.595-21.794
5Y-33.088-8.315-24.773
10Y-69.409-8.708-60.701
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hofseth Biocare ASA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.74 means the investor is paying kr8.74 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Hofseth Biocare ASA:

  • The EOD is 5.579. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.740. Based on the equity, the company is overpriced. -1
  • The TTM is 8.740. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.579MRQ8.740-3.161
MRQ8.740TTM8.7400.000
TTM8.740YOY19.419-10.679
TTM8.7405Y16.811-8.071
5Y16.81110Y19.263-2.452
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.5791.905+3.674
MRQ8.7402.111+6.629
TTM8.7402.095+6.645
YOY19.4192.836+16.583
5Y16.8113.443+13.368
10Y19.2633.794+15.469
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hofseth Biocare ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0210.0210%-0.312+1580%0.057-63%0.038-44%
Book Value Per Share--0.3760.3760%0.355+6%0.383-2%0.258+46%
Current Ratio--1.0211.0210%1.128-10%1.606-36%1.274-20%
Debt To Asset Ratio--0.6380.6380%0.663-4%0.573+11%0.650-2%
Debt To Equity Ratio--1.7641.7640%1.954-10%1.422+24%2.183-19%
Dividend Per Share----0%-0%-0%-0%
Eps---0.347-0.3470%-0.320-8%-0.273-21%-0.234-33%
Free Cash Flow Per Share---0.159-0.1590%-0.252+58%-0.191+20%-0.178+11%
Free Cash Flow To Equity Per Share--0.0880.0880%-0.311+454%0.020+343%-0.002+102%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.744--------
Intrinsic Value_10Y_min---2.173--------
Intrinsic Value_1Y_max---0.188--------
Intrinsic Value_1Y_min---0.233--------
Intrinsic Value_3Y_max---0.554--------
Intrinsic Value_3Y_min---0.691--------
Intrinsic Value_5Y_max---0.909--------
Intrinsic Value_5Y_min---1.136--------
Market Cap829659600.000-57%1299816588.7001299816588.7000%2726024400.000-52%2480290437.740-48%1775078122.870-27%
Net Profit Margin---1.141-1.1410%-1.443+27%-1.354+19%-2.154+89%
Operating Margin---1.068-1.0680%-1.353+27%-1.241+16%-1.955+83%
Operating Ratio--2.8312.8310%3.090-8%2.995-5%4.128-31%
Pb Ratio5.579-57%8.7408.7400%19.419-55%16.811-48%19.263-55%
Pe Ratio-6.050+36%-9.479-9.4790%-21.556+127%-24.001+153%-23.006+143%
Price Per Share2.100-57%3.2903.2900%6.900-52%6.278-48%4.493-27%
Price To Free Cash Flow Ratio-13.181+36%-20.650-20.6500%-27.389+33%-33.088+60%-69.409+236%
Price To Total Gains Ratio99.526-57%155.924155.9240%-22.093+114%58.372+167%34.090+357%
Quick Ratio--0.2550.2550%0.380-33%0.936-73%0.694-63%
Return On Assets---0.334-0.3340%-0.304-9%-0.323-3%-0.371+11%
Return On Equity---0.924-0.9240%-0.897-3%-0.787-15%-1.178+28%
Total Gains Per Share--0.0210.0210%-0.312+1580%0.057-63%0.038-44%
Usd Book Value--13473669.60013473669.6000%12718246.800+6%13710534.240-2%9248402.700+46%
Usd Book Value Change Per Share--0.0020.0020%-0.028+1580%0.005-63%0.003-44%
Usd Book Value Per Share--0.0340.0340%0.032+6%0.035-2%0.023+46%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.031-0.0310%-0.029-8%-0.025-21%-0.021-33%
Usd Free Cash Flow---5702907.600-5702907.6000%-9017418.000+58%-6829210.560+20%-6357637.560+11%
Usd Free Cash Flow Per Share---0.014-0.0140%-0.023+58%-0.017+20%-0.016+11%
Usd Free Cash Flow To Equity Per Share--0.0080.0080%-0.028+454%0.002+343%0.000+102%
Usd Market Cap75167159.760-57%117763382.936117763382.9360%246977810.640-52%224714313.659-48%160822077.932-27%
Usd Price Per Share0.190-57%0.2980.2980%0.625-52%0.569-48%0.407-27%
Usd Profit---12447443.400-12447443.4000%-11457547.800-8%-9783332.280-21%-8363213.520-33%
Usd Revenue--10912588.80010912588.8000%7938009.600+37%7353712.080+48%5973765.360+83%
Usd Total Gains Per Share--0.0020.0020%-0.028+1580%0.005-63%0.003-44%
 EOD+2 -6MRQTTM+0 -0YOY+21 -125Y+12 -2110Y+19 -14

3.2. Fundamental Score

Let's check the fundamental score of Hofseth Biocare ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.050
Price to Book Ratio (EOD)Between0-15.579
Net Profit Margin (MRQ)Greater than0-1.141
Operating Margin (MRQ)Greater than0-1.068
Quick Ratio (MRQ)Greater than10.255
Current Ratio (MRQ)Greater than11.021
Debt to Asset Ratio (MRQ)Less than10.638
Debt to Equity Ratio (MRQ)Less than11.764
Return on Equity (MRQ)Greater than0.15-0.924
Return on Assets (MRQ)Greater than0.05-0.334
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Hofseth Biocare ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.635
Ma 20Greater thanMa 502.140
Ma 50Greater thanMa 1002.268
Ma 100Greater thanMa 2002.457
OpenGreater thanClose2.140
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in NOK. All numbers in thousands.

Summary
Total Assets411,030
Total Liabilities262,314
Total Stockholder Equity148,716
 As reported
Total Liabilities 262,314
Total Stockholder Equity+ 148,716
Total Assets = 411,030

Assets

Total Assets411,030
Total Current Assets175,754
Long-term Assets235,282
Total Current Assets
Cash And Cash Equivalents 29,881
Net Receivables 14,072
Inventory 116,525
Other Current Assets 12,730
Total Current Assets  (as reported)175,754
Total Current Assets  (calculated)173,208
+/- 2,546
Long-term Assets
Property Plant Equipment 168,798
Intangible Assets 60,588
Other Assets 6,832
Long-term Assets  (as reported)235,282
Long-term Assets  (calculated)236,218
+/- 936

Liabilities & Shareholders' Equity

Total Current Liabilities172,223
Long-term Liabilities90,772
Total Stockholder Equity148,716
Total Current Liabilities
Short Long Term Debt 540
Accounts payable 145,746
Other Current Liabilities 1
Total Current Liabilities  (as reported)172,223
Total Current Liabilities  (calculated)146,287
+/- 25,936
Long-term Liabilities
Long term Debt Total 89,960
Other Liabilities -1
Long-term Liabilities  (as reported)90,772
Long-term Liabilities  (calculated)89,959
+/- 813
Total Stockholder Equity
Common Stock3,951
Capital Surplus 144,765
Total Stockholder Equity (as reported)148,716
Total Stockholder Equity (calculated)148,716
+/-0
Other
Capital Stock3,951
Cash and Short Term Investments 29,881
Common Stock Shares Outstanding 395,081
Liabilities and Stockholders Equity 411,030
Net Invested Capital 150,068
Net Tangible Assets 89,096
Net Working Capital 3,520
Property Plant and Equipment Gross 365,424



Balance Sheet

Currency in NOK. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
205,052
217,868
193,348
159,353
184,239
187,945
293,012
459,134
415,973
411,030
411,030415,973459,134293,012187,945184,239159,353193,348217,868205,052
   > Total Current Assets 
90,830
106,489
87,725
37,481
94,891
100,319
137,853
271,470
170,311
175,754
175,754170,311271,470137,853100,31994,89137,48187,725106,48990,830
       Cash And Cash Equivalents 
3,969
2,539
28,872
15,157
40,671
48,641
93,211
170,712
47,211
29,881
29,88147,211170,71293,21148,64140,67115,15728,8722,5393,969
       Net Receivables 
59,784
52,030
6,959
4,366
30,456
17,661
5,561
14,267
10,089
14,072
14,07210,08914,2675,56117,66130,4564,3666,95952,03059,784
       Inventory 
25,829
51,044
50,818
15,589
16,858
29,402
33,986
73,302
90,813
116,525
116,52590,81373,30233,98629,40216,85815,58950,81851,04425,829
   > Long-term Assets 
0
0
0
121,872
89,348
87,626
155,160
187,664
245,662
235,282
235,282245,662187,664155,16087,62689,348121,872000
       Property Plant Equipment 
88,484
84,690
81,472
104,683
68,088
67,361
128,353
137,955
185,831
168,798
168,798185,831137,955128,35367,36168,088104,68381,47284,69088,484
       Goodwill 
7,458
7,458
7,458
0
0
0
0
0
0
0
00000007,4587,4587,458
       Long Term Investments 
0
886
1,444
960
3,654
2,909
1,734
0
0
0
0001,7342,9093,6549601,4448860
       Intangible Assets 
0
6,149
3,111
16,227
17,606
17,255
24,347
42,434
53,130
60,588
60,58853,13042,43424,34717,25517,60616,2273,1116,1490
       Long-term Assets Other 
0
0
0
2
-5
202
155,160
54
-75
-5
-5-7554155,160202-52000
> Total Liabilities 
143,050
138,919
160,802
105,790
147,156
101,901
175,262
195,370
275,595
262,314
262,314275,595195,370175,262101,901147,156105,790160,802138,919143,050
   > Total Current Liabilities 
107,289
92,803
74,735
60,152
102,813
71,514
71,753
106,179
150,933
172,223
172,223150,933106,17971,75371,514102,81360,15274,73592,803107,289
       Short-term Debt 
96,650
21,769
3,075
25,315
33,479
23,266
21,979
0
0
0
00021,97923,26633,47925,3153,07521,76996,650
       Short Long Term Debt 
96,650
21,769
3,075
25,315
33,479
23,266
21,979
3,428
2,420
540
5402,4203,42821,97923,26633,47925,3153,07521,76996,650
       Accounts payable 
35,582
30,295
55,436
25,147
51,929
32,112
29,712
84,956
124,165
145,746
145,746124,16584,95629,71232,11251,92925,14755,43630,29535,582
       Other Current Liabilities 
10,608
7,131
6,742
6,198
9,245
3,210
2,975
10,251
12,600
1
112,60010,2512,9753,2109,2456,1986,7427,13110,608
   > Long-term Liabilities 
0
0
0
45,638
44,343
30,387
103,509
89,191
124,662
90,772
90,772124,66289,191103,50930,38744,34345,638000
       Long term Debt Total 
0
0
0
45,638
21,512
12,921
92,018
85,424
123,311
89,960
89,960123,31185,42492,01812,92121,51245,638000
       Capital Lease Obligations 
0
0
0
14,848
10,118
17,567
81,971
72,302
112,977
102,815
102,815112,97772,30281,97117,56710,11814,848000
       Other Liabilities 
210
1,080
0
0
1
-1
-1
-1
-1
-1
-1-1-1-1-11001,080210
> Total Stockholder Equity
62,622
79,590
33,194
54,221
37,748
86,717
118,432
264,448
141,063
148,716
148,716141,063264,448118,43286,71737,74854,22133,19479,59062,622
   Common Stock
77,536
98,036
110,410
233,500
233,500
294,837
325,821
3,578
3,578
3,951
3,9513,5783,578325,821294,837233,500233,500110,41098,03677,536
   Retained Earnings 
-14,914
-18,446
-77,216
-179,279
-195,752
-208,120
-208,216
15,477
139,185
0
0139,18515,477-208,216-208,120-195,752-179,279-77,216-18,446-14,914
   Capital Surplus 
0
0
0
0
0
0
827
236,709
137,485
144,765
144,765137,485236,709827000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
0
0
0
0
827
8,684
0
145,733
145,73308,684827000000



Balance Sheet

Currency in NOK. All numbers in thousands.




Cash Flow

Currency in NOK. All numbers in thousands.




Income Statement

Currency in NOK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue181,058
Cost of Revenue-128,883
Gross Profit52,17552,175
 
Operating Income (+$)
Gross Profit52,175
Operating Expense-293,193
Operating Income-112,135-241,018
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense293,1930
 
Net Interest Income (+$)
Interest Income567
Interest Expense-9,956
Other Finance Cost-0
Net Interest Income-9,389
 
Pretax Income (+$)
Operating Income-112,135
Net Interest Income-9,389
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-93,013-112,135
EBIT - interestExpense = -9,956
-93,011
-83,055
Interest Expense9,956
Earnings Before Interest and Taxes (EBIT)--83,057
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-93,013
Tax Provision-0
Net Income From Continuing Ops-93,013-93,013
Net Income-93,011
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-9,389
 

Technical Analysis of Hofseth Biocare ASA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hofseth Biocare ASA. The general trend of Hofseth Biocare ASA is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hofseth Biocare ASA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hofseth Biocare ASA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.38 < 2.39 < 2.76.

The bearish price targets are: 2 > 2 > 1.9.

Tweet this
Hofseth Biocare ASA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hofseth Biocare ASA. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hofseth Biocare ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hofseth Biocare ASA. The current macd is -0.04441293.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hofseth Biocare ASA price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hofseth Biocare ASA. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hofseth Biocare ASA price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hofseth Biocare ASA Daily Moving Average Convergence/Divergence (MACD) ChartHofseth Biocare ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hofseth Biocare ASA. The current adx is 29.89.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hofseth Biocare ASA shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Hofseth Biocare ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hofseth Biocare ASA. The current sar is 1.91940664.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hofseth Biocare ASA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hofseth Biocare ASA. The current rsi is 44.63. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Hofseth Biocare ASA Daily Relative Strength Index (RSI) ChartHofseth Biocare ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hofseth Biocare ASA. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hofseth Biocare ASA price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hofseth Biocare ASA Daily Stochastic Oscillator ChartHofseth Biocare ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hofseth Biocare ASA. The current cci is -52.64438282.

Hofseth Biocare ASA Daily Commodity Channel Index (CCI) ChartHofseth Biocare ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hofseth Biocare ASA. The current cmo is -9.85156776.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hofseth Biocare ASA Daily Chande Momentum Oscillator (CMO) ChartHofseth Biocare ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hofseth Biocare ASA. The current willr is -39.39393939.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hofseth Biocare ASA is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hofseth Biocare ASA Daily Williams %R ChartHofseth Biocare ASA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hofseth Biocare ASA.

Hofseth Biocare ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hofseth Biocare ASA. The current atr is 0.14025006.

Hofseth Biocare ASA Daily Average True Range (ATR) ChartHofseth Biocare ASA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hofseth Biocare ASA. The current obv is -11,528,285.

Hofseth Biocare ASA Daily On-Balance Volume (OBV) ChartHofseth Biocare ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hofseth Biocare ASA. The current mfi is 7.92046454.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Hofseth Biocare ASA Daily Money Flow Index (MFI) ChartHofseth Biocare ASA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hofseth Biocare ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Hofseth Biocare ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hofseth Biocare ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.635
Ma 20Greater thanMa 502.140
Ma 50Greater thanMa 1002.268
Ma 100Greater thanMa 2002.457
OpenGreater thanClose2.140
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hofseth Biocare ASA with someone you think should read this too:
  • Are you bullish or bearish on Hofseth Biocare ASA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hofseth Biocare ASA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hofseth Biocare ASA

I send you an email if I find something interesting about Hofseth Biocare ASA.


Comments

How you think about this?

Leave a comment

Stay informed about Hofseth Biocare ASA.

Receive notifications about Hofseth Biocare ASA in your mailbox!